A study on the optimum fast neutron flux for Boron Neutron Capture Therapy of deep-seated tumors

被引:10
作者
Rasouli, Fatemeh S. [1 ]
Masoudi, S. Farhad [1 ]
机构
[1] KN Toosi Univ Technol, Dept Phys, Tehran, Iran
关键词
BNCT; In-air parameters; Fast neutron dose; Skin damage; MCNP simulation; ACCELERATOR-BASED BNCT; SKIN MELANOMA; HEAD PHANTOM; BEAM; DESIGN; GLIOBLASTOMA; OPTIMIZATION; SPECTRUM; FACILITY; TRIAL;
D O I
10.1016/j.apradiso.2014.11.016
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
High-energy neutrons, named fast neutrons which have a number of undesirable biological effects on tissue, are a challenging problem in beam designing for Boron Neutron Capture Therapy, BNCT. In spite of this fact, there is not a widely accepted criterion to guide the beam designer to determine the appropriate contribution of fast neutrons in the spectrum. Although a number of researchers have proposed a target value for the ratio of fast neutron flux to epithermal neutron flux, it can be shown that this criterion may not provide the optimum treatment condition. This simulation study deals with the determination of the optimum contribution of fast neutron flux in the beam for BNCT of deep-seated tumors. Since the dose due to these high-energy neutrons damages shallow tissues, delivered dose to skin is considered as a measure for determining the acceptability of the designed beam. To serve this purpose, various beam shaping assemblies that result in different contribution of fast neutron flux are designed. The performances of the neutron beams corresponding to such configurations are assessed in a simulated head phantom. It is shown that the previously used criterion, which suggests a limit value for the contribution of fast neutrons in beam, does not necessarily provide the optimum condition. Accordingly, it is important to specify other complementary limits considering the energy of fast neutrons. By analyzing various neutron spectra, two limits on fast neutron flux are proposed and their validity is investigated. The results show that considering these limits together with the widely accepted IAEA criteria makes it possible to have a more realistic assessment of sufficiency of the designed beam. Satisfying these criteria not only leads to reduction of delivered dose to skin, but also increases the advantage depth in tissue and delivered dose to tumor during the treatment time. The Monte Carlo Code, MCNP-X, is used to perform these simulations. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 35 条
[1]  
[Anonymous], 2001, IAEATECDOC1223
[2]   Measurement of free beam neutron spectra at eight BNCT facilities worldwide [J].
Auterinen, I ;
Serén, T ;
Anttila, K ;
Kosunen, A ;
Savolainen, S .
APPLIED RADIATION AND ISOTOPES, 2004, 61 (05) :1021-1026
[3]   Boron neutron capture therapy of cancer: Current status and future prospects [J].
Barth, RF ;
Coderre, JA ;
Vicente, MGH ;
Blue, TE .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :3987-4002
[4]   Designing accelerator-based epithermal neutron beams for boron neutron capture therapy [J].
Bleuel, DL ;
Donahue, RJ ;
Ludewigt, BA ;
Vujic, J .
MEDICAL PHYSICS, 1998, 25 (09) :1725-1734
[5]   Applicability of the 9Be(d,n)10B reaction to AB-BNCT skin and deep tumor treatment [J].
Capoulat, M. E. ;
Minsky, D. M. ;
Kreiner, A. J. .
APPLIED RADIATION AND ISOTOPES, 2011, 69 (12) :1684-1687
[6]   The BSA modeling for the accelerator-based BNCT facility at INFN LNL for treating shallow skin melanoma [J].
Ceballos, C. ;
Esposito, J. .
APPLIED RADIATION AND ISOTOPES, 2009, 67 (7-8) :S274-S277
[7]   Spectrum shaping assessment of accelerator-based fusion neutron sources to be used in BNCT treatment [J].
Cerullo, N ;
Esposito, J ;
Daquino, GG .
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 2004, 213 :641-645
[8]   An irradiation facility for Boron Neutron Capture Therapy application based on a radio frequency driven D-T neutron source and a new beam shaping assembly [J].
Cerullo, N ;
Esposito, J ;
Leung, KN ;
Custodero, S .
REVIEW OF SCIENTIFIC INSTRUMENTS, 2002, 73 (10) :3614-3618
[9]   Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory [J].
Chadha, M ;
Capala, J ;
Coderre, JA ;
Elowitz, EH ;
Iwai, J ;
Joel, DD ;
Liu, HYB ;
Wielopolski, L ;
Chanana, AD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (04) :829-834
[10]   Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results [J].
Coderre, JA ;
Elowitz, EH ;
Chadha, M ;
Bergland, R ;
Capala, J ;
Joel, DD ;
Liu, HYB ;
Slatkin, DN ;
Chanana, AD .
JOURNAL OF NEURO-ONCOLOGY, 1997, 33 (1-2) :141-152